Published 09/25/2024 11:04:00 a.m.

Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices

Senator Bernie Sanders confronted Novo Nordisk’s CEO over high prices for Ozempic and Wegovy, stating that 40,000 lives could be lost annually if costs remain high.
Sanders argued that Novo Nordisk charges Americans significantly more for its drugs compared to other countries.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

CNN

‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable.

09/24/2024 6:38:10 p.m.·Atlanta, United States

Read Full Article

Globo

Why is Ozempic so expensive? Figures show that it is increasingly difficult for Novo Nordisk to justify its price

Revenue for the drug and its counterpart Wegovy is expected to reach US$ 65 billion by the end of this year, almost the same amount invested by the pharmaceutical company in research over the last three decades. The sales of the Danish pharmaceutical company Novo Nordisk with Ozempic and Wegovy are so high that sales of the two drugs will soon exceed the company's entire research budget over the past three decades, data compiled by Bloomberg sho…

09/24/2024 11:24:42 a.m.·Brazil

Read Full Article

CNBC

‘Stop ripping us off': Senate grills Novo Nordisk CEO on weight loss drug pricing

Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.

09/24/2024 11:00:01 a.m.·United States

Read Full Article

The Hill

Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite repeatedly being pressed by Sen. Bernie Sanders (I-Vt.), chair of the Senate Committee on Health, Education, Labor and Pensions (HELP). Novo Nordisk chief Lars Fruergaard Jørgensen told senators Tuesday that pharmacy benefit managers (PBMs), the industry middlemen that negotiate the terms and conditions for access to pre…

09/24/2024 9:42:03 p.m.·Washington, United States

Read Full Article

Bloomberg

Sanders Says Ozempic’s High Price Risks Lives in Tense Hearing

Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen found himself struggling to defend the price of blockbuster drugs Ozempic and Wegovy in a congressional hearing Tuesday where Senator Bernie Sanders accused the drugmaker of prioritizing profits over American lives.

09/24/2024 2:39:18 p.m.·United States

Read Full Article